Fox 19: UC doctor part of team developing new COVID-19 antibody test
Transplant surgeon discusses ‘good’ and ‘bad’ antibodies along with false positives
Steve Woodle, MD, William A. Altemeier Chair in Research Surgery at the UC College of Medicine, is part of a national team working on a new test that can determine the effectiveness of antibodies against COVID-19 and also does a better job of reducing false positives in detecting the novel coronavirus.
“There’s scientific evidence that is accumulating, indicating that some antibodies can be good for you and some antibodies may be bad for you,” Woodle, a UC Health transplant surgeon, told Fox 19. “This test looks at five different types of antibodies and picks out particular combinations that exist in people who get well and people who struggle with recovering from the virus.”
The new test developed by a team of researchers at UC, Emory University and Toronto’s University Health Network along with Thermo Fisher Scientific can reduce the number of false positives for COVID-19, possibly triggered because a patient has antibodies for a common cold.
“No other test has that built into it that’s currently available in the market, but this test brings that,” Woodle told viewers.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.